| Literature DB >> 26826492 |
Hongen Li1, Yutao Chen2, Bing Zhang1, Xiaodi Niu1, Meng Song1, Zhaoqing Luo3, Gejin Lu1, Bowen Liu1, Xiaoran Zhao1, Jianfeng Wang4, Xuming Deng5.
Abstract
The critical role of sortase A in gram-positive bacterial pathogenicity makes this protein a good potential target for antimicrobial therapy. In this study, we report for the first time the crystal structure of Listeria monocytogenes sortase A and identify the active sites that mediate its transpeptidase activity. We also used a sortase A (SrtA) enzyme activity inhibition assay, simulation, and isothermal titration calorimetry analysis to discover that chalcone, an agent with little anti-L. monocytogenes activity, could significantly inhibit sortase A activity with an IC50 of 28.41 ± 5.34 μM by occupying the active site of SrtA. The addition of chalcone to a co-culture of L. monocytogenes and Caco-2 cells significantly inhibited bacterial entry into the cells and L. monocytogenes-mediated cytotoxicity. Additionally, chalcone treatment decreased the mortality of infected mice, the bacterial burden in target organs, and the pathological damage to L. monocytogenes-infected mice. In conclusion, these findings suggest that chalcone is a promising candidate for the development of treatment against L. monocytogenes infection.Entities:
Keywords: Anti-infection; Chalcone; Listeria monocytogenes; Sortase A
Mesh:
Substances:
Year: 2016 PMID: 26826492 DOI: 10.1016/j.bcp.2016.01.018
Source DB: PubMed Journal: Biochem Pharmacol ISSN: 0006-2952 Impact factor: 5.858